Business
Amplia Completes Dosing in Phase 1 Clinical Study of AMP945
Amplia Completes Dosing in Phase 1 Clinical Study of AMP945
About this update from Amplia Therapeutics Ltd.
[{"type":"text","content":"Amplia Therapeutics Ltd has released a press release. View Attachment","length":250,"tagName":"div"}]